HPV Vaccine: Israel Health Ministry Considers Canceling Vaccination Due to Side Effects
Rochester, NY (PRWEB) September 04, 2013 -- The CBCD has learned that “Health Ministry officials (in Israel) are considering canceling plans to administer the HPV vaccine to 52,000 eighth-grade girls, following studies suggesting vaccine-linked autoimmune conditions and other adverse effects (1).”
These studies are causing concern among experts in Israel’s much respected medical community. One such study was conducted by Israeli and Italian medical experts from Sheba Medical Center, Tel Hashomer, and Sapienza University of Rome. It was published in July 2013 in the American Journal of Reproductive Immunology (1).
The study described “patients who had adverse effects after being administered a vaccine against the human papilloma virus aimed at preventing infection with species of the virus associated with the development of cervical cancer (1).”
In fact, the authors wrote that there is “evidence of the potential of the HPV vaccine to trigger a life-disabling autoimmune condition.” They further wrote that “The increasing number of similar reports of post HPV vaccine-linked autoimmunity and the uncertainty of long-term clinical benefits of HPV vaccination are a matter of public health that warrants further rigorous inquiry (1).”
Advocates of the HPV vaccine argue that those who resist vaccination are uninformed and ignorant. However, the doctors and medical researchers who turned to the Israeli Health Ministry with concerns about the HPV vaccine, are regarded as some of the leading health professionals in the country (1).
The Israeli Health Ministry’s decision on the HPV vaccine raises serious questions regarding the CDC’s renewed push for HPV Vaccinations for Pre-teens of both sexes, as reported in an article published on Newsmax.com (2). The article was published on August 28th, 2013.
“We wonder why the CDC and FDA are pushing Gardasil so strongly when health ministries in other countries are expressing concern. It seems that experts around the world, from Japan to Israel to Italy are re-evaluating the safety record of the HPV vaccine, while American health officials prefer to ignore it.” – Greg Bennett, CBCD
The Center believes that the poor safety record of the HPV vaccine is due to the fragments of foreign DNA contained in the vaccine. The CBCD suggests that these foreign DNA fragments could be a cause of the autoimmune conditions observed by the Israeli scientists, as suggested by Dr. Hanan Polansky’s Microcompetition with Foreign DNA Theory.
In fact, in September of 2012, the CBCD sent a letter to the offices of the FDA Commissioner, Dr. Margaret Hamburg,and to the offices of the CDC’s director, Dr. Thomas R. Frieden. This letter predicted the results of the studies by the Israeli scientists, and warned the FDA & CDC about the side effects reported in them.
The CBCD therefore calls on American health officials to follow the Israeli Health Ministry’s example and start its own re-evaluation of the HPV vaccines.
For more information on the Center for the Biology of Chronic Disease and the dangers posed by foreign DNA, visit http://www.cbcd.net. To request an interview or to speak with a CBCD official, please Email info (AT) CBCD (DOT) net.
References:
(1) http://www.haaretz.com/news/national/.premium-1.545014
(2) http://www.newsmax.com/us/hpv-vaccines-cdc/2013/08/28/id/522720
###
The CBCD is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments.
The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between foreign DNA and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.
Hanan Polansky, Center for the Biology of Chronic Disease (CBCD), +1 (585) 250-9999, [email protected]
Share this article